News

Public · Published

HIMS Q3'26 Earnings: revenue estimate is 892.88M USD

Hims & Hers Health is scheduled to announce Q3 2026 results on November 9 after the market closes, with disclosure expected at 4:05 p.m. ET. The supplied estimate is revenue of 892.88 million USD and earnings per share, or profit per share, of 0.06 USD.

Published:

Updated:

What happened

Hims & Hers Health is scheduled to announce Q3 2026 results on November 9 after the market closes, with disclosure expected at 4:05 p.m. ET. The supplied estimate is revenue of 892.88 million USD and earnings per share, or profit per share, of 0.06 USD.

Confirmed

Global impact / market context

The estimates set expectations for sales and profit per share before the report. If actual results differ, investors may reassess the company’s ability to grow revenue and generate profit, which can influence their decisions about Hims & Hers shares and the company’s funding for business operations.

Analyst inference

Hims & Hers is scheduled to report Q3'26 results after the market closes on November 09, with revenue estimated at 892.88M USD and earnings per share expected at 0.06 USD. The figures are forecasts, not reported results. If achieved, revenue growth could support sales, but earnings and costs determine how much reaches profit.

Analyst inference

What to watch

  1. Check the announced Q3 revenue against the 892.88 million USD estimate; the difference will show whether reported sales met the expectation stated in the article. Confirmed
  2. Compare reported earnings per share with the 0.06 USD estimate; earnings per share means profit allocated to each share, and a shortfall could weaken confidence in profitability. Analyst inference
  3. Look for management’s explanation of sales and costs in the results; those details can clarify whether revenue growth is translating into stronger profit or requiring more spending. Analyst inference

Evidence

  • Original source link unavailable